Dr. Mehmet Oz, the expected nominee for US Centers for Medicare and Medicaid Services administrator, and other lower-level appointees could be in position to substantially alter the second round of Medicare drug pricing negotiation.
Medicare Price Negotiation Under CMS Chief Oz May See Early 2025 Test
The next round of the negotiation program is scheduled to begin in February unless the new administration delays the start of the process.
